COVID-19: Pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetes

The novel SARS-CoV-2 coronavirus (COVID-19) has become a global health crisis since its initial outbreak in Wuhan, China in December 2019. On January 30, 2020, the WHO recognized the COVID-19 outbreak as a Public Health Emergency, and on March 11, 2020, it was declared a pandemic. Although all age g...

Descripción completa

Detalles Bibliográficos
Autores principales: Mason, Kelly, Hasan, Sana, Darukhanavala, Amy, Kutney, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Special Issue: COVID19 and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545686/
https://www.ncbi.nlm.nih.gov/pubmed/34722160
http://dx.doi.org/10.1016/j.jcte.2021.100268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545686/
https://www.ncbi.nlm.nih.gov/pubmed/34722160
http://dx.doi.org/10.1016/j.jcte.2021.100268

Ejemplares similares